Alpha Omega Wealth Management’s Fifth Third Bancorp FITB Stock Holding History

Alpha Omega Wealth Management’s Portfolio FITB Stock Details FITB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-60	Closed	-$2K	–	339
2019 Q2	$2K	Buy	+60	New	+$1.65K	﹤0.01%	559

Other funds holding FITB

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alpha Omega Wealth Management's FITB Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Fifth Third Bancorp (FITB) in Q3 2019, closing a stake of 60 shares — an estimated $2K sold.

Alpha Omega Wealth Management first reported a position in FITB in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 730 funds tracked by Wall St. Rank hold FITB as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Fifth Third Bancorp position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 60 Fifth Third Bancorp shares in Q3 2019, an estimated $2K.
Alpha Omega Wealth Management first reported a position in Fifth Third Bancorp in Q2 2019 and held it in 1 quarter.
Alpha Omega Wealth Management's Fifth Third Bancorp position peaked at $2K in Q2 2019.
730 funds tracked by Wall St. Rank held Fifth Third Bancorp as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.